ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally. The company engages in manufacturing medical devices and cosmetics; research, design, production, and sales of biological tissue implants; and dental and orthopedic implants, collagen, and related derivative products. It also offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. ACRO Biomedical Co., Ltd. was founded in 2014 and is based in Kaohsiung, Taiwan.
Frequently asked questions
What sector does ACRO Biomedical Co., Ltd. (6748) operate in?
ACRO Biomedical Co., Ltd. belongs to the Other sector and operates in the Biotechnology industry.
What is ACRO Biomedical Co., Ltd. (6748) current stock price?
As of the latest data, ACRO Biomedical Co., Ltd. stock price is NT$178.00, with a previous close of NT$186.50. ACRO Biomedical Co., Ltd. lost -NT$8.50 in the last trading session, representing a -4.56% loss.
What is ACRO Biomedical Co., Ltd. (6748) current market capitalization?
ACRO Biomedical Co., Ltd. market cap is approximately 12.68 billion.
What is ACRO Biomedical Co., Ltd. (6748) Earnings Per Share (EPS)?
The trailing EPS is -NT$1.36.
Does ACRO Biomedical Co., Ltd. (6748) pay dividends?
No. ACRO Biomedical Co., Ltd. does not pay a dividend.
What is ACRO Biomedical Co., Ltd. (6748) beta (volatility) score?
ACRO Biomedical Co., Ltd. has a beta of 0.196, indicating lower volatility than the overall market.
